MedTrace Logo

Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema

NCT00675454 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 802

Last updated 2021-12-02

No results posted yet for this study

Summary

Emphysema is a lung disease that involves damage to the air sacs in the lungs and can lead to breathing difficulties. Treatment options for people with emphysema include pulmonary rehabilitation, lung volume reduction surgery, and lung transplantation. This study will observe people with emphysema to assess the effect of these treatment therapies on their quality of life and long-term health.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Emphysema

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Roger D. Yusen, MD, MPH · Washington University School of Medicine, St. Louis

Eligibility

Min Age
35 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2015-09-11
Completion
2015-09-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00675454 on ClinicalTrials.gov